NCT06999837RecruitingPhase 1/2
Evaluation of Multiparametric dynamic whole-body 68Ga-PSMA PET imaging for Hepatocellular Carcinoma recurrence. HIMIKO study.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 31 Aug 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 11 Feb 2025
- Start date
- 23 Sept 2025
- Lead sponsor
- Centre Hospitalier Universitaire De Nantes
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT06999837
- EU CT number
- 2024-515178-28-00
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 40
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hopital Beaujon Coordinator of this site? Confirm its status | Clichy | France | Recruiting |
| Centre Hospitalier Universitaire De Nantes Coordinator of this site? Confirm its status | Nantes Cedex 1 | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.